JW Holdings signs supply agreement of ‘ertapenem’ ingredients with Indian Grand Pharma
JW Holdings will enter advanced markets, such as the U.S. Canada, through exports of ‘ertapenem’ ingredients, a next-generation antibiotic.
The company announced on the 24th that it signed an agreement to supply ‘ertapenem’ ingredients worth of the total USD 26 million and exclusively sell its f...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
